AGP
CVS icon

Aspire Growth Partners’s CVS Health CVS Stock Holding History

Aspire Growth Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$448K Sell
4,334
-333
-7% -$29.7K 0.26% 74
2026
Q1 		$335K Sell
4,667
-301
-6% -$23.2K 0.23% 87
2025
Q4 		$394K Buy
4,968
+43
+0.9% +$3.39K 0.27% 82
2025
Q3 		$371K Sell
4,925
-404
-8% -$27.7K 0.27% 82
2025
Q2 		$368K Sell
5,329
-358
-6% -$23.5K 0.3% 78
2025
Q1 		$380K Buy
5,687
+291
+5% +$17.4K 0.34% 71
2024
Q4 		$242K Buy
+5,396
New +$303K 0.24% 87

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Aspire Growth Partners's CVS Position: Q2 2026 in Review

Aspire Growth Partners reduced its CVS Health (CVS) stake by 7.1% in Q2 2026, selling an estimated $29.7K and leaving 4,334 shares worth $448K. The position accounts for 0.26% of the portfolio, ranked #74.

Aspire Growth Partners first reported a position in CVS in Q4 2024 and has held it in 7 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Aspire Growth Partners held 4,334 shares of CVS Health worth $448K as of Q2 2026.
  • Aspire Growth Partners sold 333 CVS Health shares in Q2 2026, an estimated $29.7K.
  • CVS Health made up 0.26% of Aspire Growth Partners's portfolio in Q2 2026, its #74 holding.
  • Aspire Growth Partners first reported a position in CVS Health in Q4 2024 and has held it in 7 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Aspire Growth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.